Detalhe da pesquisa
1.
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment.
Br J Surg
; 110(9): 1143-1152, 2023 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37471574
2.
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial.
Lancet Oncol
; 23(12): 1571-1582, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370716
3.
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 23(7): 876-887, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35636444
4.
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial.
Eur Respir J
; 60(4)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35361632
5.
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial.
Ann Surg Oncol
; 29(9): 5732-5744, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35552930
6.
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 22(10): 1438-1447, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34499874
7.
FOLFOXIRI-Bevacizumab or FOLFOX-Panitumumab in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Propensity Score-Based Analysis.
Oncologist
; 26(4): 302-309, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33336844
8.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32164906
9.
EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer.
Breast Cancer Res
; 22(1): 83, 2020 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32758299
10.
Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL).
Br J Cancer
; 123(1): 26-32, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32346071
11.
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer.
BMC Cancer
; 20(1): 683, 2020 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32698790
12.
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial.
Breast Cancer Res
; 21(1): 71, 2019 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31142370
13.
Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study.
Br J Cancer
; 119(11): 1326-1331, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30405211
14.
Phase II Study of Preoperative Treatment with External Radiotherapy Plus Panitumumab in Low-Risk, Locally Advanced Rectal Cancer (RaP Study/STAR-03).
Oncologist
; 23(8): 912-918, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29523646
15.
The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients.
BMC Cancer
; 18(1): 98, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29370781
16.
Evaluation of candidemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year period.
Infection
; 46(4): 469-476, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29654496
17.
New perspectives on the long-term outcome of segmental colectomy for Crohn's colitis: an observational study on 200 patients.
Int J Colorectal Dis
; 33(4): 479-485, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29511841
18.
Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer.
Br J Cancer
; 116(3): 318-323, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28081548
19.
Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
N Engl J Med
; 371(17): 1609-18, 2014 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25337750
20.
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.
BMC Cancer
; 17(1): 408, 2017 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28599628